From the cash flow statements in the accounts 2008 to 2015
Total loans received £52.97m - of that £4.6m is from monies advanced as a loan by purchaser against the sale of Prozone
Total loans repaid £10.8m - including £4.6m Prozone loan repaid
Preference shares issued to repay loans (and some interest?) £4.3m
The original loan in the 2009 accounts was 11m. Because of the way the deal was done that loan included £9m for the purchase the CCFC H Group net assets( net assets fair value of assets & liabilities taken on £8m plus £1m consideration), basically the investors took on the cash flow of the business that's not the same as paying cash in. SBS&L Group largely met that cash flow from its operations as CCFC. In addition there was a value of £1m put on the option to purchase the ACL shares this was a valuation not an actual purchase. the actual consideration to purchase the group was around £1m but the "loans" will show more on top of that because the way the deal was done. It looks like there was actual cash flow funding in 2008/09 of £2m(11m - 8m-1m)
In addition the creditors taken over 2008 included payments due to certain creditors of £6.4m should we get promoted, we didn't and the amount was written off as a loss.
Loans outstanding on purchase 2008 - £ 0
Loans outstanding 31-05-15 - £40.55
Arvo £7.75
SISU investors £28.5m
ARVO Preference shares £4.3m
However factoring in the above narrative and the actual cash from SISU investors would seem to be nearer £19.5m (not a small sum but not as great as we might have thought certainly not £60m ) The potential loss to ARVO & SISU investors seems nearer to £31m
SBS&L Group Losses at purchase of CCFC in 2008 - £0
SBS&L Group losses at 31-05-15 - £49.2m
(which includes the £6.4m mentioned above, the purchase out of administration written off 1.5m, devaluation of Ryton £400k, Writing down the option value £1m, Goodwill write off 1.3m and a profit on disposal of Prozone)
Just my take on it - others might see it differently,